The StandardPlus service lets customers add an additional antibody to Teiko’s Standard 41-marker peripheral blood mononuclear cell (PBMC) or whole blood (WB) mass cytometry (CyTOF) panel to detect a specific marker of interest. Drug developers often need to track a specific cell type, target, pathway, or a general marker of interest in their clinical trials. Now, with Teiko, it’s simple. You pick an antibody, and we verify that antibody on a CLIA-validated backbone.